Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Flanagan

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Clinical Epigenetics|August 6, 2015
Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosisKarin van Veldhoven, Silvia Polidoro, Laura Baglietto, et al.
Breast Cancer Research : BCR|September 6, 2022
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studiesPierre-Antoine Dugué, Clara Bodelon, Felicia F Chung, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Clinical Epigenetics|May 2, 2019
Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer riskAnnelie Johansson, Domenico Palli, Giovanna Masala, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Plos One|November 27, 2013
Methylome analysis and epigenetic changes associated with menarcheal ageChristiana A Demetriou, Jia Chen, Silvia Polidoro, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical Epigenetics|August 6, 2015
Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosisKarin van Veldhoven, Silvia Polidoro, Laura Baglietto, et al.
Breast Cancer Research : BCR|September 6, 2022
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studiesPierre-Antoine Dugué, Clara Bodelon, Felicia F Chung, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Clinical Epigenetics|May 2, 2019
Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer riskAnnelie Johansson, Domenico Palli, Giovanna Masala, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Plos One|November 27, 2013
Methylome analysis and epigenetic changes associated with menarcheal ageChristiana A Demetriou, Jia Chen, Silvia Polidoro, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.
Pageof 8